Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plant-based vaccines: unique advantages.

S J Streatfield1, J M Jilka, E E Hood

  • 1ProdiGene, College Station, TX 77845, USA.

Vaccine
|March 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occupational Intakes of Radionuclides: Part 5.

Annals of the ICRP·2022
Same author

Update on clinical trials of kidney stone repositioning and preclinical results of stone breaking with one system.

Proceedings of meetings on acoustics. Acoustical Society of America·2020
Same author

An in vivo demonstration of efficacy and acute safety of burst wave lithotripsy using a porcine model.

Proceedings of meetings on acoustics. Acoustical Society of America·2020
Same author

ICRP Publication 141: Occupational Intakes of Radionuclides: Part 4.

Annals of the ICRP·2019
Same author

False-Positive Reactions in the Immunoprecipitation Test for Meat Identification.

Journal of food protection·2019
Same author

Estimation of lung absorption parameters for oxides of <sup>238</sup>Pu.

Journal of radiological protection : official journal of the Society for Radiological Protection·2018
Same journal

V-safe: Summary of findings reported after COVID-19 vaccination to a US CDC active safety surveillance system through June 2023.

Vaccine·2026
Same journal

In silico selection and in vivo evaluation of scoloptoxin SSD14, Rm-inositol monophosphatase, and Rm-neprilysin as potential anti-tick vaccines.

Vaccine·2026
Same journal

Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults.

Vaccine·2026
Same journal

Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.

Vaccine·2026
Same journal

Public health benefits of maternal influenza vaccination among pregnant women and infants <6 months in the United States, 2011-2020.

Vaccine·2026
Same journal

Effectiveness and acceptability of an opt-out nudge to promote influenza vaccination among medical residents: A randomized controlled trial.

Vaccine·2026
See all related articles

Transgenic corn successfully produced key antigens from E. coli and a swine virus, demonstrating potential for safe, cost-effective, and globally accessible plant-based vaccines.

Area of Science:

  • Plant molecular biology
  • Vaccinology
  • Biotechnology

Background:

  • Recombinant proteins, including viral epitopes and bacterial toxin subunits, can be expressed in transgenic plants.
  • Plant-based vaccines offer advantages like safety, cost-effectiveness, stability, and efficacy over traditional methods.
  • Corn is a promising platform for vaccine production due to its high yield, scalability, and ambient temperature transport capabilities.

Purpose of the Study:

  • To evaluate the feasibility of expressing specific antigens in corn.
  • To determine if these plant-expressed antigens can elicit protective immune responses.

Main Methods:

  • High-level expression of the B-subunit of Escherichia coli heat-labile enterotoxin and the spike protein of swine transmissible gastroenteritis virus in corn.

Related Experiment Videos

  • Analysis of antigen processing and stability within the corn seed.
  • Assessment of immune responses and protective efficacy in response to oral administration of the corn-delivered antigens.

    • Main Results:

    • Successful high-level expression of both target antigens in corn seeds.
    • Demonstrated that the corn-delivered antigens are processed and stable.
    • Confirmed that the antigens elicit protective immune responses.

    Conclusions:

    • Transgenic corn can effectively express and deliver functional vaccine antigens.
    • Corn-based vaccines hold significant potential for global health initiatives due to their economic and logistical advantages.
    • This study validates plant-based antigen delivery systems for infectious disease prevention.